Over 54K People Screened Under TB-Free India Drive In MP's Narmadapuram
More than 54,000 people have been screened under the Prime Minister’s TB-free India campaign

Madhya Pradesh: Over 54K People Screened Under TB-Free India Drive In Narmadapuram |
Narmadapuram (Madhya Pradesh): More than 54,000 people have been screened under the Prime Minister’s TB-free India campaign in the district, official sources said.
A target has been fixed for checking 3.06 lakh people under the campaign. TB-screening staff, CHOs, ANMs, and Asha workers have so far examined 54,986 people.
TB screening work is underway in all development blocks of Narmadapuram under the campaign. Ten TB patients were given fruit baskets under the guidance of chief medical and health officer, Dr Narsingh Gehlot.
TB screening camps have been held in central jail, student hostels, Rain Baseras, and slum areas.
The administration has so far made 158 Nikshay Mitras (those who fight against TB), and they are distributing food baskets among the patients.
The central government is giving financial aid of ₹ 1,000 a month to TB patients through DBT until they complete treatment, sources further said.
Collector Sonia Meena and Dr Gehlot appealed to those who are above 60 years old and are addicted to smoking to get checked up.
Similarly, those whose body mass index (BMI) is less than 18 and who are prone to coughs and colds should also visit nearby health centres to get examined, the collector and CMHO said.
District TB officer Dr Sanjay Purohit, DPC Vishesh Dubey, and others were present at the function where food baskets were distributed among TB patients.
RECENT STORIES
-
Who Is Khalid Jamil? Details About The First Indian Coach To Take Charge Of The Men's National Team... -
International Girlfriend's Day: Here Are 10 Fun Date Ideas You Should Plan With Your Partner -
ICSE, ISC Improvement Results 2025 Declared At cisce.org; Direct Link Here -
Godrej Properties Reports 15% Increase In Net Profit To ₹598.40 Crore For The First Quarter -
Trump Tells 17 Global Drug Firms To Cut Prices In US, Nifty Pharma Falls Amid Market Concerns